Acute Mental Fatigue and Muscle Strength
Florida Institute for Human and Machine Cognition · NCT07846618
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–39 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 50
- US sites recruiting
- 1
- Study start
- September 23, 2026
- Record last updated
- September 29, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study will investigate the acute effects of mental fatigue on lower-extremity muscle strength and limb symmetry in healthy young adults. Participants will complete lower-extremity strength testing before and after a standardized computer-based mental fatigue protocol involving tasks of attention, reaction time, concentration, and working memory. Muscle strength and limb symmetry will be assessed using isokinetic dynamometry, with muscle activity measured using surface electromyography. Participants will also complete subjective measures of mental fatigue, sleepiness, mental effort, and perceived physical exertion. Heart rate will be monitored throughout the study, and brain activity may be assessed during cognitive tasks. The study will determine whether acute mental fatigue is associated with changes in muscle strength, limb symmetry, and neuromuscular performance.
Being studied: Computer-Based Mental Fatigue Protocol
Conditions: Mental Fatigue; Muscle Strength Dynamometer
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 18-39 years
- Able to produce maximal force against Biodex protocol
- Able to perform required lower extremity movements through range of motion necessary for Biodex protocol
- No known cognitive impairment
- Sufficient musculoskeletal health to complete the tasks
Exclusion Criteria
- History of a neurological disorder, disease, or cognitive impairment that may affect cognition, motor control, reaction time, or force production
- History of musculoskeletal injury affecting the lower extremities within the past 6 months
- History of lower extremity surgery affecting force production of the hip, knee, or ankle
- Color-vision impairment
- Significant visual or hearing impairment
- History of migraine headaches
- Current significant sleep disturbances or sleep deprivation
- Head injury that may affect cognitive function
- Medical condition affecting ability to produce maximal force safely
- Allergy to adhesive tape, parabens, or propylene glycol
- Scalp lacerations, open wounds, or sutures on the scalp
- Cranial surgery or skull defects
- History of unexplained dizziness or fainting in the past 6 months
- Individuals who are pregnant, prisoners, or not yet adults
- Inability to communicate with investigators
- Inability to provide written informed consent
Recruiting US locations
Florida Institute for Human and Machine Cognition
Pensacola, FL 32502
Site contact: Nicole Rendos, PhD · 850-202-4442 · nrendos@ihmc.org
Study contacts (from the official record)
- Nicole K Rendos, PhD · 850-202-4442 · nrendos@ihmc.org
Similar studies in Florida
All healthy volunteers studies in Florida →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4302814 in Healthy Participants
Eli Lilly and Company
- Location
- Daytona Beach, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Orlando, FL + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol
BioCorRx Pharmaceuticals Inc
- Location
- Miami, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Miami, FL + 6 other US sites
- Eligibility basics
- Ages 18–65